(Q40718234)

23 September 2017

title

Oestrogen and progesterone receptors in breast cancer: past, present and future (English)

1 reference

23 September 2017

1 reference

Barnes DM

1

1 reference

23 September 2017

Hanby AM

series ordinal

2

1 reference

23 September 2017

publication date

1 March 2001

1 reference

23 September 2017

1 reference

23 September 2017

volume

38

1 reference

23 September 2017

issue

3

1 reference

23 September 2017

page(s)

271-274

1 reference

Specific estrogen binding by the cytoplasm fof human breast carcinoma.

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01060.X

Monoclonal antibodies to human estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01060.X

Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01060.X

Standardization of steroid receptor assays in human breast cancer--I. Reproducibility of estradiol and progesterone receptor assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01060.X

Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01060.X

Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. UK Receptor Group, UK NEQAS, The Scottish Breast Cancer Pathology Group, and The Receptor and Biomarker Study Group of the EORTC

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01060.X

Expression and functional role of E- and P-cadherins in mouse mammary ductal morphogenesis and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01060.X

A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01060.X

Predicting Response to Endocrine Therapy in Human Breast Cancer: A Hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01060.X

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01060.X

Oestrogen receptors and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01060.X

UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01060.X

CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL FOR BREAST CANCER

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01060.X

10.1046/J.1365-2559.2001.01060.X

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference